Litigation Details for In Re: BRCA1- and BRCA2- Based Hereditary Cancer Test Patent Litigation (D. Utah 2014)
✉ Email this page to a colleague
In Re: BRCA1- and BRCA2- Based Hereditary Cancer Test Patent Litigation (D. Utah 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-02-24 |
| Court | District Court, D. Utah | Date Terminated | 2015-03-09 |
| Cause | 35:0271 Patent Infringement | Assigned To | Robert James Shelby |
| Jury Demand | Both | Referred To | |
| Patents | 6,051,379; 6,083,698 | ||
| Link to Docket | External link to docket | ||
Biologic Drugs cited in In Re: BRCA1- and BRCA2- Based Hereditary Cancer Test Patent Litigation
The biologic drug covered by the patents cited in this case is ⤷ Sign Up .
Details for In Re: BRCA1- and BRCA2- Based Hereditary Cancer Test Patent Litigation (D. Utah 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2014-08-07 | 133 | LPR 2.3 Contentions Eleven Claims for U.S. Patent No. 6,051,379 and Memorandum in Support filed by MDL Notice… BRCA1- and BRCA2- Based Hereditary Cancer Test Patent Litigation 25 February 2014 9… 9 March 2015 2:14-md-02510 830 Patent Both District Court, D. Utah D. Utah | External link to document | |
| 2014-08-13 | 138 | LPR 2.3 Contentions Eleven Claims for U.S. Patent No. 6,051,379 in case 2:14-md-02510-RJS. Signed by Judge… BRCA1- and BRCA2- Based Hereditary Cancer Test Patent Litigation 25 February 2014 9… 9 March 2015 2:14-md-02510 830 Patent Both District Court, D. Utah D. Utah | External link to document | |
| 2014-05-06 | 53 | the “’109 patent”); and 6,051,379 (the “’379 patent”) (collectively, the “patents-in-suit”). Myriad further… 54. United States Patent No. 6,051,379 (the “’379 Patent”) was duly and legally issued … Myriad owns United States Patent Nos. 5,654,155; 5,750,400; 6,051,379; 6,951,721; 7,250,497; 6,083,698…United States Patent Nos. 5,709,999; 5,747,282; 5,753,441; 5,837,492; 6,033,857; 6,051,379; 6,951,721; … (Infringement of United States Patent No. 6,051,379) 53. Myriad repeats | External link to document | |
| 2014-03-10 | 7 | ,400 (the ’400 Patent); claims 32 and 33 of U.S. Patent No. 6,051,379 (the ’379 Patent); claim 5 of U.…the ’473 Patent, the ’282 Patent, and the ’999 Patent. ’473 Patent col.52 ll.50-56; ’282 Patent col.53 ….S. Patent No. 5,837,492 (the ’492 Patent); claim 4 of U.S. Patent No. 6,033,857 (the ’857 Patent); claims… ’473 Patent); claim 1 of the ’999 Patent; claim 1 of U.S. Patent 5,710,001 (the ’001 Patent); claim 1…999 Patent, claim 1 of the ’001 Patent, claim 1 of ’441 Patent, claims 1 and 2 of the ’857 Patent, and | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
